Literature DB >> 10934574

Psychiatric disorders among drug dependent subjects: are they primary or secondary?

W M Compton1, L B Cottler, D L Phelps, A Ben Abdallah, E L Spitznagel.   

Abstract

The relationship between substance use disorders and comorbid psychiatric conditions was investigated among 425 persons in drug treatment who met DSM-III-R criteria for drug dependence. Using the NIMH Diagnostic Interview Schedule to ascertain DSM-III-R psychiatric disorders among these drug dependent subjects, lifetime prevalence rates were 64% for alcohol abuse/dependence, 44% for antisocial personality disorder, 39% for phobic disorders, 24% for major depression, 12% for dysthymia, and 10% for generalized anxiety disorder. We found that antisocial personality disorder and phobias generally had onsets prior to the onset of drug dependence (that is, they were primary disorders). The majority of drug dependent persons with generalized anxiety disorder reported an onset after the onset of drug dependence (that is, they had secondary generalized anxiety). Alcohol dependence, depression, and dysthymia were divided nearly evenly between earlier (primary disorder) and later (secondary disorder). These results are consistent with the body of literature indicating the importance of antisocial syndromes in the etiology of substance abuse and the literature indicating the complex, varying nature of the relationship of psychiatric disorders to substance dependence. Finally, a precise nomenclature for "age of onset," "primary," and "secondary" was developed for this study that is critical to understanding these issues and is recommended for other studies.

Entities:  

Mesh:

Year:  2000        PMID: 10934574     DOI: 10.1080/10550490050173190

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  30 in total

1.  Chronic pain and narcotics: a dilemma for primary care.

Authors:  Yngvild Olsen; Gail L Daumit
Journal:  J Gen Intern Med       Date:  2002-03       Impact factor: 5.128

2.  Association between attention-deficit/hyperactivity disorder in adolescence and substance use disorders in adulthood.

Authors:  David W Brook; Judith S Brook; Chenshu Zhang; Jonathan Koppel
Journal:  Arch Pediatr Adolesc Med       Date:  2010-10

3.  CJDATS Co-Occurring Disorders Screening Instrument for Mental Disorders (CODSI-MD): A Pilot Study.

Authors:  Stanley Sacks; Gerald Melnick; Carrie Coen; Steven Banks; Peter D Friedmann; Christine Grella; Kevin Knight
Journal:  Prison J       Date:  2007-03

4.  An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program.

Authors:  Kevin W Chen; Annie N Banducci; Leila Guller; Richard J Macatee; Anna Lavelle; Stacey B Daughters; C W Lejuez
Journal:  Drug Alcohol Depend       Date:  2011-04-22       Impact factor: 4.492

5.  Effects of periadolescent versus adult cocaine exposure on cocaine conditioned place preference and motor sensitization in mice.

Authors:  Nicole L Schramm-Sapyta; Adeola R Pratt; Danny G Winder
Journal:  Psychopharmacology (Berl)       Date:  2004-01-08       Impact factor: 4.530

6.  Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment.

Authors:  Ya-Fen Chan; Michael L Dennis; Rodney R Funk
Journal:  J Subst Abuse Treat       Date:  2007-06-15

7.  Posttraumatic Stress Disorder and Co-Occurring Substance Use Disorders: Advances in Assessment and Treatment.

Authors:  Jenna L McCauley; Therese Killeen; Daniel F Gros; Kathleen T Brady; Sudie E Back
Journal:  Clin Psychol (New York)       Date:  2012-09-01

8.  Coping styles and illicit drug use in older adults with HIV/AIDS.

Authors:  Linda M Skalski; Kathleen J Sikkema; Timothy G Heckman; Christina S Meade
Journal:  Psychol Addict Behav       Date:  2013-02-25

Review 9.  Generalised anxiety disorder: treatment options.

Authors:  John J Sramek; Victoria Zarotsky; Neal R Cutler
Journal:  Drugs       Date:  2002       Impact factor: 9.546

10.  Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits.

Authors:  M D Glantz; J C Anthony; P A Berglund; L Degenhardt; L Dierker; A Kalaydjian; K R Merikangas; A M Ruscio; J Swendsen; R C Kessler
Journal:  Psychol Med       Date:  2008-12-02       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.